<p>The Potential Role of the Pharmacist in Supporting Patients with Depression – A Literature-Based Point of View</p>

Abstract

Objective: The current article is aimed at identifying the best practice for counseling around depression in community and outpatient pharmacies, resulting in a draft guideline, proposing key steps and an algorithm for integration of community pharmacists into care for patients with depression. Methods: A literature review was performed followed by a detailed analysis, for the purpose of creation a short draft document used as a basis for creation of a guideline for pharmaceutical care for patients with depression. The technological scheme PRISMA flow diagram was applied. The paper is based on current knowledge, taking into consideration already published articles, guidelines, and recommendations about pharmaceutical care for patients with depression, giving a basis for further studies. Results: This paper includes two main sections: 1) depressiona short description of the main symptoms, risk factors and pharmacotherapy guidelines available in Bulgaria important for the purposes of ensuring qualitative community-based pharmaceutical care; and 2) the pharmacists' role in providing high-quality carethe main aspects of pharmaceutical care for patients with depression with specific examples. Conclusion: The involvement of pharmacists in supporting depressive patients is crucial taking into account the specific characteristics of the pharmacological treatment: delayed onset of clinical results, risks in case of sudden pharmacotherapy abruption without physician consultation, multiple adverse drug reactions and drug-drug, drug-food and drugalcohol interactions, etc. The current article could also be used as an initial document for creating a methodological guideline for providing pharmaceutical care services for patients with depression.

Pharmacotherapy Follow up in Mental Health: Which Outcomes Change in a Short Period?

“…[34][35][36][37] So, nonadherence to medication among patients with mental disorders must be prevented, avoiding negative clinical and economic consequences in these patients. [38][39][40] In the present study, PFS improves the adherence of treatment over the course of pharmaceutical consultations. Similarly, recent studies concluded that pharmacist interventions (counseling and treatment monitoring) improved antidepressant medication adherence by 15% to 27%.…”

Is the reduction of codes of pharmaceutical procedures a concern of society?

“…19 Problemas graves relacionados ao uso de medicamentos poderiam ser identificados ou evitados, e intervenções específicas para a prevenção e superação poderiam ser recomendadas. Situações como: falta de eficácia dos medicamentos prescritos, dose muito alta ou muito baixa, medicamentomedicamento, medicamento-suplemento alimentar ou interação medicamento-alimento podem ser identificados pelo farmacêutico 20 0101030029 Visita domiciliar/institucional por profissional de Código de procedimento farmacêutico e descrição na Agência Nacional de Saúde Suplementar (ANS) 3…”

Ролята На Фармацевта В Оптимизирането И Мониторирането На Терапията На Пациенти С Акромегалия

“…Основна задача на фармацевта е провеждането на medication review (преглед на лекарствата, които пациентът приема), като целта е оптимизиране на лекарствената употреба и подобряване на здравните резултати [2]. По този начин могат да бъдат открити лекарство-свързаните проблеми (ЛСП), както и да се препоръча провеждането на съответните интервенции за преодоляването или предотвратяването им в бъдеще.…”